DOTTIKON EXCLUSIVE SYNTHESIS AG manufactures high-quality intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading biotech and pharmaceutical industry. More than Hazardous Reactions - Exclusive Synthesis of APIs - R&D, routefinding and process development - Process intensification under cGMP - Multi-ton cGMP production - Quality management, FDA and Swissmedic approved - Over 110 years of experience in hazardous reactions - One-site strategy in Switzerland with more than 750 employees